Introducing a major advancement in proactive healthcare with a bioinformatics platform for accelerating research and commercialization of predictive algorithms in the field of diabetes.
Dallas, Texas (PRWEB) June 7, 2004 –- As participants in the Texas Pavilion at this years annual BIO 2004 conference being held in San Francisco, the worlds largest biotech trade show, Diabetech® announces the GlucoDYNAMIX System: a breakthrough bioinformatics platform in the field of diabetes.
A critical part of Diabetechs mission for accelerating advancements in the field of diabetes technology is making progress in the area of predictive algorithms. These intelligent computer programs operate in a closed loop system to generate probable outcomes using inputs such as demographics, patient-specific biometric data, behavioral patterns, and more. With automated access to patient data, GlucoDYNAMIX brings down the lifecycle costs of designing, developing, testing and ultimately deploying a complex real-time biomechanical brain for automating the risk assessment process and recommending potential interventions. This collaborative work will also contribute to a more robust artificial pancreas in the future. Access to Diabetechs GlucoDYNAMIX system is unique in the field of diabetes and is recognized for its virtual-loop design and the high availability and accuracy of the data.
Diabetech is the only company in the world to produce a real-time go-anywhere technology for diabetes management thats invisible – it doesnt require a PDA, cable connections or learning a new computer program. This end-to-end, automated system is breaking new ground now as we begin the development of complex algorithms within specialized Intensive Management Protocols (IMPs) – packages of finely tuned reports, reminders and alerts that streamline the flow of information to various members of the diabetes team. These pre-designed clinical management modules take time and complexity out while guiding the patient to better blood sugar control and in a safer environment," says Kevin McMahon, President of Diabetech. Finally, a diabetes management technology that addresses the specific information needs associated with managing the newly diagnosed, those starting on an insulin pump and other high risk scenarios while always taking into account the individual needs of each patient and their team."
GlucoDYNAMIX is made possible by Diabetechs proprietary GlucoMON wireless device that is embedded in the case of the patients glucose meter. The GlucoMON takes the blood-glucose data from the meter each time a patient tests and wirelessly sends the data to the GlucoDYNAMIX system. Then, built-in intelligence distributes information to the appropriate caregiver at the appropriate time, and in the appropriate format. Each caregiver is in control of when and how they access the patients information. IMPs ensure that no one gets too much information or in a format they cant use," says McMahon.
Stephen Ponder, an Endocrinologist and Certified Diabetes Educator calls Diabetechs method for collecting and distributing patient data, Ridiculously easy." The real difference is having access to real-time patient data to analyze, look for trends and find exceptions to high-risk thresholds in real-time. Within seconds, GlucoDYNAMIX closes the loop.
Learn more about the GlucoDYNAMIX System at www.diabetech.net. Inquiries or requests for a copy of the white paper entitled: The Real-time Virtual Loop: Collection through Intervention" may be directed to Hilary Hale, Vice President of Corporate Communications, at hilary@diabetech.net.
About Diabetech
Diabetech is a Dallas, Texas based biomedical technology service provider helping people achieve improved outcomes within the GlucoDYNAMIX proactive diabetes management care system. This wholly managed service is available to connect the patients extended management team in order to intelligently share information, analyze patient data and proactively intervene. www.diabetech.net.
###
|
